Thomas Joseph Dee
Corporate Officer/Principal en Abbott Laboratories Trading (Shanghai) Co. Ltd. .
Cargos activos de Thomas Joseph Dee
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Abbott Laboratories Trading (Shanghai) Co. Ltd.
Abbott Laboratories Trading (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Abbott Laboratories Trading (Shanghai) Co., Ltd. is a subsidiary of Abbott Laboratories SA. It primarily offers medicines. The company is headquartered in Shanghai, China. | Corporate Officer/Principal | 22/09/2011 | - |
Historial de carrera de Thomas Joseph Dee
Antiguos cargos conocidos de Thomas Joseph Dee.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AVEXIS INC | Director Financiero/CFO | 01/08/2015 | 19/10/2017 |
ABBOTT INDIA LIMITED | Director/Miembro de la Junta | 09/04/2008 | 30/09/2013 |
Independent Dir/Board Member | 22/09/2011 | 26/04/2013 | |
ABBOTT LABORATORIES | Comptroller/Controller/Auditor | 01/01/1990 | 01/04/2011 |
Corporate Officer/Principal | 01/04/2011 | 01/09/2013 |
Formación de Thomas Joseph Dee.
Northern Illinois University | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 5 |
India | 2 |
China | 2 |
Operativa
Corporate Officer/Principal | 2 |
Comptroller/Controller/Auditor | 1 |
Director/Board Member | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ABBOTT LABORATORIES | Health Technology |
ABBOTT INDIA LIMITED | Health Technology |
Empresas privadas | 2 |
---|---|
Abbott Laboratories Trading (Shanghai) Co. Ltd.
Abbott Laboratories Trading (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Abbott Laboratories Trading (Shanghai) Co., Ltd. is a subsidiary of Abbott Laboratories SA. It primarily offers medicines. The company is headquartered in Shanghai, China. | Health Technology |
Novartis Gene Therapies, Inc.
Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Thomas Joseph Dee
- Experiencia